Alexander S. Mankin

12.3k citations

151 papers · 9.1k indexed · 1 hit paper · h-index 56

Co-authors: Nora Vázquez‐Laslop Liqun Xiong Tanel Tenson Dorota Klepacki Norbert Polacek Haripriya Ramu Krishna Kannan J.A. Dunkle
Topics: RNA and protein synthesis mechanisms (130 papers)RNA modifications and cancer (76 papers)Bacterial Genetics and Biotechnology (67 papers)
Cited by: Molecular Medicine Microbiology Molecular Biology
Journals: Nature Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: United States Russia Germany

In The Last Decade

Alexander S. Mankin

151 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A broad-spectrum lasso peptide antibiotic targeting the bacterial ribosome

2025 24 citations Elena V. Aleksandrova, Dorota Klepacki et al. Nature profile →

Peers

Countries citing papers authored by Alexander S. Mankin

Since Specialization

Citations

This map shows the geographic impact of Alexander S. Mankin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander S. Mankin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander S. Mankin more than expected).

Fields of papers citing papers by Alexander S. Mankin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander S. Mankin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander S. Mankin. The network helps show where Alexander S. Mankin may publish in the future.

Co-authorship network of co-authors of Alexander S. Mankin

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander S. Mankin. A scholar is included among the top collaborators of Alexander S. Mankin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander S. Mankin. Alexander S. Mankin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Paenilamicins are context-specific translocation inhibitors of protein synthesis 2024 ·Nature Chemical Biology ·(unknown),(unknown),(unknown),Helge Paternoga,(unknown),(unknown),Tam Dang,Andi Mainz,(unknown),Caillan Crowe‐McAuliffe,Marco Scocchi,Mario Mardirossian,Bertrand Beckert,Nora Vázquez‐Laslop,Alexander S. Mankin,Roderich D. Süßmuth,Daniel N. Wilson	2
2	Activity, structure, and diversity of Type II proline-rich antimicrobial peptides from insects 2024 ·EMBO Reports ·Weiping Huang,(unknown),Elena V. Aleksandrova,Gemma C. Atkinson,Yury S. Polikanov,Nora Vázquez‐Laslop,Alexander S. Mankin	5
3	Sequence diversity of apidaecin-like peptides arresting the terminating ribosome 2024 ·Nucleic Acids Research ·Weiping Huang,(unknown),Nora Vázquez‐Laslop,Alexander S. Mankin	2
4	A method for tritiation of iboxamycin permits measurement of its ribosomal binding 2023 ·Bioorganic & Medicinal Chemistry Letters ·Kelvin J. Y. Wu,Dorota Klepacki,Alexander S. Mankin,Andrew G. Myers	3
5	Structure–Activity Relationships of the Antimicrobial Peptide Natural Product Apidaecin 2023 ·Journal of Medicinal Chemistry ·(unknown),(unknown),T. Johnson,(unknown),(unknown),(unknown),A’Lester C. Allen,(unknown),Elena V. Aleksandrova,Dorota Klepacki,Alexander S. Mankin,Yury S. Polikanov,Terry W. Moore	15
6	The context of the ribosome binding site in mRNAs defines specificity of action of kasugamycin, an inhibitor of translation initiation 2022 ·Proceedings of the National Academy of Sciences ·Yan Zhang,Nikolay A. Aleksashin,Dorota Klepacki,(unknown),Nora Vázquez‐Laslop,Carol A. Gross,Alexander S. Mankin	15
7	A synthetic antibiotic class overcoming bacterial multidrug resistance 2021 ·Nature ·Matthew J. Mitcheltree,Amarnath Pisipati,Egor A. Syroegin,(unknown),Dorota Klepacki,Jeremy D. Mason,(unknown),Giambattista Testolin,(unknown),Kelvin J. Y. Wu,(unknown),Kelly Chatman,Alexander S. Mankin,Yury S. Polikanov,Andrew G. Myers	170
8	Context-specific action of macrolide antibiotics on the eukaryotic ribosome 2021 ·Nature Communications ·Maxim S. Svetlov,(unknown),Sezen Meydan,(unknown),Dorota Klepacki,Norbert Polacek,Nicholas R. Guydosh,Nora Vázquez‐Laslop,Daniel N. Wilson,Alexander S. Mankin	22
9	Structure of Erm-modified 70S ribosome reveals the mechanism of macrolide resistance 2021 ·Nature Chemical Biology ·Maxim S. Svetlov,Egor A. Syroegin,Elena V. Aleksandrova,Gemma C. Atkinson,Steven T. Gregory,Alexander S. Mankin,Yury S. Polikanov	90
10	Mechanism of translation inhibition by type II GNAT toxin AtaT2 2020 ·Nucleic Acids Research ·(unknown),(unknown),(unknown),Marina V. Serebryakova,(unknown),(unknown),(unknown),Ilya А. Osterman,Петр В. Сергиев,Sergei Borukhov,Nora Vázquez‐Laslop,Alexander S. Mankin,Konstantin Severinov,Svetlana Dubiley	11
11	Ribosome engineering reveals the importance of 5S rRNA autonomy for ribosome assembly 2020 ·Nature Communications ·Shijie Huang,Nikolay A. Aleksashin,A.B. Loveland,Dorota Klepacki,(unknown),Amira Kefi,Teresa Szal,Jaanus Rèmme,Luc Jaeger,Nora Vázquez‐Laslop,А.A. Коростелев,Alexander S. Mankin	25
12	Genome-wide effects of the antimicrobial peptide apidaecin on translation termination in bacteria 2020 ·eLife ·(unknown),Tanja Florin,Xinhao Shao,Dorota Klepacki,Irina Chelysheva,Zoya Ignatova,Yu Gao,Alexander S. Mankin,Nora Vázquez‐Laslop	31
13	A fully orthogonal system for protein synthesis in bacterial cells 2020 ·Nature Communications ·Nikolay A. Aleksashin,Teresa Szal,Anne E. d’Aquino,Michael C. Jewett,Nora Vázquez‐Laslop,Alexander S. Mankin	43
14	A long-distance rRNA base pair impacts the ability of macrolide antibiotics to kill bacteria 2020 ·Proceedings of the National Academy of Sciences ·Maxim S. Svetlov,(unknown),Nada Alsuhebany,Nora Vázquez‐Laslop,Alexander S. Mankin	12
15	Engineered ribosomes with tethered subunits for expanding biological function 2019 ·Nature Communications ·Erik D. Carlson,Anne E. d’Aquino,Do Soon Kim,(unknown),Kim L. Hoang,Teresa Szal,Alexander S. Mankin,Michael C. Jewett	55
16	Dynamics of the context-specific translation arrest by chloramphenicol and linezolid 2019 ·Nature Chemical Biology ·Junhong Choi,James Marks,Jingji Zhang,Dong-Hua Chen,Jinfan Wang,Nora Vázquez‐Laslop,Alexander S. Mankin,Joseph D. Puglisi	34
17	Co-produced natural ketolides methymycin and pikromycin inhibit bacterial growth by preventing synthesis of a limited number of proteins 2017 ·Nucleic Acids Research ·Mashal M. Almutairi,Maxim S. Svetlov,Douglas A. Hansen,Nelli F. Khabibullina,Dorota Klepacki,Han‐Young Kang,David H. Sherman,Nora Vázquez‐Laslop,Yury S. Polikanov,Alexander S. Mankin	26
18	An antimicrobial peptide that inhibits translation by trapping release factors on the ribosome 2017 ·Nature Structural & Molecular Biology ·Tanja Florin,Cristina Maracci,Michael Graf,Prajwal Karki,Dorota Klepacki,Otto Berninghausen,Roland Beckmann,Nora Vázquez‐Laslop,Daniel N. Wilson,Marina V. Rodnina,Alexander S. Mankin	133
19	Inactivation of the Indigenous Methyltransferase RlmN in Staphylococcus aureus Increases Linezolid Resistance 2011 ·Antimicrobial Agents and Chemotherapy ·Jacqueline M. LaMarre,Benjamin P. Howden,Alexander S. Mankin	39
20	Erythromycin- and Chloramphenicol-Induced Ribosomal Assembly Defects Are Secondary Effects of Protein Synthesis Inhibition 2008 ·Antimicrobial Agents and Chemotherapy ·Triinu Siibak,Lauri Peil,Liqun Xiong,Alexander S. Mankin,Jaanus Rèmme,Tanel Tenson	62

About Alexander S. Mankin

Alexander S. Mankin is a scholar working on Genetics, Molecular Medicine and Molecular Biology, having authored 151 papers that have together received 9.1k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (130 papers), RNA modifications and cancer (76 papers) and Bacterial Genetics and Biotechnology (67 papers). The work is most often cited by research in Molecular Medicine (1.2k citations), Microbiology (651 citations) and Molecular Biology (6.9k citations). Alexander S. Mankin has collaborated with scholars based in United States, Russia and Germany. Frequent co-authors include Nora Vázquez‐Laslop, Liqun Xiong, Tanel Tenson, Dorota Klepacki, Norbert Polacek, Haripriya Ramu, Krishna Kannan, J.A. Dunkle, J.H.D. Cate and Dean L. Shinabarger. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact